Growth Metrics

Myomo (MYO) Other financing activities (2017 - 2025)

Myomo posted quarterly Other financing activities of $583991.0 for Q3 2025, up 80.14% year-on-year from $324185.0 in Q3 2024, and up 47.89% on a QoQ basis from $394889.0 in Q2 2025.

Myomo (MYO) has 9 years of Other financing activities data on file, last reported at $583991.0 in Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities rose 80.14% year-over-year to $583991.0; the trailing twelve-month figure through Sep 2025 stood at $2.6 million (up 56.2% YoY), and the FY2024 full-year result was $874438.0, down 21.62% from the prior year.
  • Other financing activities for Q3 2025 stood at $583991.0, up from $394889.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.1 million in Q4 2023 and bottomed at -$91893.0 in Q2 2024.
  • The 5-year median for Other financing activities is $322236.5 (2024), against an average of $391559.6.
  • The widest annual swing landed in 2024, when Other financing activities tumbled 132.81%; it then soared 529.73% in 2025.
  • A 5-year view of Other financing activities shows it stood at $265362.0 in 2021, then gained by 15.18% to $305633.0 in 2022, then surged by 262.35% to $1.1 million in 2023, then retreated by 3.03% to $1.1 million in 2024, then slumped by 45.62% to $583991.0 in 2025.
  • The last three Other financing activities figures came in at $583991.0 (Q3 2025), $394889.0 (Q2 2025), and $540204.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 583,991.00
Sep 30, 2025 583,991.00
Jun 30, 2025 394,889.00
Jun 30, 2025 394,889.00
Mar 31, 2025 540,204.00
Mar 31, 2025 540,204.00
Dec 31, 2024 1.07 Mn
Dec 31, 2024 1.07 Mn
Sep 30, 2024 324,185.00
Sep 30, 2024 324,185.00
Jun 30, 2024 -91,893.00
Jun 30, 2024 -91,893.00
Mar 31, 2024 320,288.00
Mar 31, 2024 320,288.00
Dec 31, 2023 1.11 Mn
Dec 31, 2023 1.11 Mn
Sep 30, 2023 330,394.00
Sep 30, 2023 330,394.00
Jun 30, 2023 280,061.00
Jun 30, 2023 280,061.00
Mar 31, 2023 171,027.00
Mar 31, 2023 171,027.00
Sep 30, 2022 305,633.00
Sep 30, 2022 305,633.00
Jun 30, 2022 345,223.00
Jun 30, 2022 345,223.00
Mar 31, 2022 266,270.00
Mar 31, 2022 266,270.00
Dec 31, 2021 265,362.00
Dec 31, 2021 265,362.00
Sep 30, 2021 301,763.00
Sep 30, 2021 301,763.00
Jun 30, 2021 363,312.00
Jun 30, 2021 363,312.00
Mar 31, 2021 165,971.00
Mar 31, 2021 165,971.00
Dec 31, 2020 616,157.00
Dec 31, 2020 616,157.00
Sep 30, 2020 181,702.00
Sep 30, 2020 181,702.00
Jun 30, 2020 106,281.00
Jun 30, 2020 106,281.00
Mar 31, 2020 123,209.00
Mar 31, 2020 123,209.00
Dec 31, 2019 988,314.00
Dec 31, 2019 988,314.00
Sep 30, 2019 146,951.00
Sep 30, 2019 146,951.00
Jun 30, 2019 197,028.00
Jun 30, 2019 197,028.00
Mar 31, 2019 396,325.00
Mar 31, 2019 396,325.00
Dec 31, 2018 171,705.00
Dec 31, 2018 171,705.00
Sep 30, 2018 150,881.00
Sep 30, 2018 150,881.00
Jun 30, 2018 155,725.00
Jun 30, 2018 155,725.00
Mar 31, 2018 336,355.00
Mar 31, 2018 336,355.00
Dec 31, 2017 167,789.00
Dec 31, 2017 167,789.00